Gsk (GSK) Total Liabilities (2009 - 2026)
Gsk (GSK) posted Total Liabilities of $60.1 billion for Q4 2025, up 0.92% on a QoQ basis from $59.5 billion in Q4 2024, and up 0.92% year-over-year from $59.5 billion in Q4 2024.
Gsk (GSK) has 11 years of Total Liabilities data on file, last reported at $60.1 billion in Q4 2025.
- In Q4 2025, Total Liabilities rose 0.92% year-over-year to $60.1 billion; the TTM figure through Dec 2025 stood at $60.1 billion (up 0.92% YoY), while the FY2025 annual figure was $60.1 billion, up 0.92% from the prior year.
- Total Liabilities advanced to $60.1 billion in Q4 2025, from $59.5 billion in the prior quarter.
- Across five years, Total Liabilities topped out at $77.9 billion in Q4 2021 and bottomed at $57.4 billion in Q4 2023.
- A 5-year average of $62.7 billion and a median of $59.5 billion in 2024 frame the typical range for Total Liabilities.
- Annual changes were most pronounced in 2022 — Total Liabilities dropped 24.6% — and 2024, when it gained 3.79%.
- Year by year, Total Liabilities stood at $77.9 billion in 2021, then dropped by 24.6% to $58.7 billion in 2022, then decreased by 2.3% to $57.4 billion in 2023, then rose by 3.79% to $59.5 billion in 2024, then advanced by 0.92% to $60.1 billion in 2025.
- The last three Total Liabilities figures came in at $60.1 billion (Q4 2025), $59.5 billion (Q4 2024), and $57.4 billion (Q4 2023), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Novartis Ag | 107,124,802.25 Bn | 107,124,802.25 Bn | - | - |
| 2 | Eli Lilly | 969.00 Bn | 963.72 Bn | 16.22 Bn | 85.38 Bn |
| 3 | Johnson & Johnson | 539.46 Bn | 517.41 Bn | 15.96 Bn | 119.71 Bn |
| 4 | AbbVie | 376.92 Bn | 367.57 Bn | 10.78 Bn | 143.08 Bn |
| 5 | Merck | 285.00 Bn | 279.35 Bn | 12.09 Bn | 82.75 Bn |
| 6 | Amgen | 177.58 Bn | 165.55 Bn | 5.87 Bn | 83.31 Bn |
| 7 | Gilead Sciences | 163.22 Bn | 155.50 Bn | 5.52 Bn | 32.76 Bn |
| 8 | Pfizer | 145.86 Bn | 133.09 Bn | -1.21 Bn | 117.21 Bn |
| 9 | Bristol Myers Squibb | 111.90 Bn | 101.44 Bn | 8.07 Bn | 66.37 Bn |
| 10 | Gsk | 88.34 Bn | 83.66 Bn | - | 60.07 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -61.27 Bn |
| Dec 31, 2025 | -60.07 Bn |
| Sep 30, 2025 | -61.51 Bn |
| Jun 30, 2025 | -59.90 Bn |
| Mar 31, 2025 | -59.26 Bn |
| Dec 31, 2024 | 59.52 Bn |
| Sep 30, 2024 | -57.94 Bn |
| Jun 30, 2024 | -55.91 Bn |
| Mar 31, 2024 | -57.44 Bn |
| Dec 31, 2023 | 57.35 Bn |
| Sep 30, 2023 | -61.11 Bn |
| Jun 30, 2023 | -59.19 Bn |
| Mar 31, 2023 | -57.47 Bn |
| Dec 31, 2022 | 58.71 Bn |
| Sep 30, 2022 | -60.81 Bn |
| Jun 30, 2022 | -83.62 Bn |
| Mar 31, 2022 | -24.39 Bn |
| Dec 31, 2021 | 77.86 Bn |
| Sep 30, 2021 | -78.50 Bn |
| Jun 30, 2021 | -77.48 Bn |
| Mar 31, 2021 | -78.69 Bn |
| Dec 31, 2020 | 78.73 Bn |
| Jun 30, 2020 | -80.09 Bn |
| Mar 31, 2020 | -82.40 Bn |
| Dec 31, 2019 | 78.86 Bn |
| Sep 30, 2019 | -80.39 Bn |
| Jun 30, 2019 | -78.03 Bn |
| Mar 31, 2019 | -76.80 Bn |
| Dec 31, 2018 | 69.99 Bn |
| Sep 30, 2018 | -71.53 Bn |
| Jun 30, 2018 | -74.40 Bn |
| Mar 31, 2018 | -73.13 Bn |
| Dec 31, 2017 | 70.22 Bn |
| Sep 30, 2017 | -70.60 Bn |
| Jun 30, 2017 | -68.76 Bn |
| Mar 31, 2017 | -66.45 Bn |
| Dec 31, 2016 | 67.28 Bn |
| Sep 30, 2016 | -72.02 Bn |
| Jun 30, 2016 | -76.69 Bn |
| Mar 31, 2016 | -68.71 Bn |
| Dec 31, 2015 | -67.63 Bn |
| Sep 30, 2015 | -69.70 Bn |
| Jun 30, 2015 | -67.26 Bn |
| Mar 31, 2015 | -70.66 Bn |
| Dec 31, 2014 | -56.59 Bn |
| Sep 30, 2014 | -57.76 Bn |
| Jun 30, 2014 | -53.87 Bn |
| Mar 31, 2014 | -53.41 Bn |
| Dec 31, 2013 | -55.49 Bn |
| Sep 30, 2013 | -53.18 Bn |
| Jun 30, 2013 | -53.43 Bn |
| Mar 31, 2013 | -54.84 Bn |
| Dec 31, 2012 | 1.52 Bn |
| Sep 30, 2012 | -52.81 Bn |
| Jun 30, 2012 | -54.92 Bn |
| Mar 31, 2012 | -49.09 Bn |
| Dec 31, 2011 | 1.35 Bn |
| Sep 30, 2011 | -53.43 Bn |
| Jun 30, 2011 | -53.23 Bn |
| Mar 31, 2011 | -52.35 Bn |
| Dec 31, 2010 | -51.32 Bn |
| Sep 30, 2010 | -49.67 Bn |
| Jun 30, 2010 | -50.02 Bn |
| Mar 31, 2010 | -51.71 Bn |
| Dec 31, 2009 | -52.47 Bn |
| Sep 30, 2009 | -52.20 Bn |
| Jun 30, 2009 | -43.25 Bn |
| Mar 31, 2009 | -44.16 Bn |